Recent diagnostic procedures for colorectal cancer screening: are they cost-effective?
Arab Journal of Gastroenterology. 2017; 18 (3): 136-139
en Inglés
| IMEMR
| ID: emr-191304
ABSTRACT
Colorectal cancer [CRC] is the third most common cancer worldwide and the fourth most common cause of death. Reduction in mortality rates in some countries worldwide are most likely ascribed to CRC screening and/or improved treatments. We reviewed the most relevant articles which discuss the cost-effectiveness of colorectal cancer screening procedures, in particular, the recent ones through the last eight years. The effectiveness of screening estimated by discounted life years gained [LYGs] compared to no screening, differed considerably between the studies. Despite these differences, all studies consistently emphasized that screening for CRC was cost-effective compared with no screening for each of the recognized screening strategies. Newer technologies for colorectal cancer screening, including computed tomographic colonography [CTC], faecal DNA test, and Pillcam Colon are less invasive and accurate, however, they are not cost-effective, as their cost was higher than all other established screening strategies. When compliance and adherence to such new techniques are increased more than the established strategies they would be more cost-effective particularly CTC
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Tipo de estudio:
Evaluación Económica en Salud
/
Estudio de tamizaje
Idioma:
Inglés
Revista:
Arab J. Gastroenterol.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS